187 related articles for article (PubMed ID: 19862666)
21. Anandamide induces cell death through lipid rafts in hepatic stellate cells.
Yang Q; Liu HY; Zhang YW; Wu WJ; Tang WX
J Gastroenterol Hepatol; 2010 May; 25(5):991-1001. PubMed ID: 20059638
[TBL] [Abstract][Full Text] [Related]
22. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
[TBL] [Abstract][Full Text] [Related]
23. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
[TBL] [Abstract][Full Text] [Related]
24. Effects of cannabinoid receptors on skeletal muscle oxidative pathways.
Cavuoto P; McAinch AJ; Hatzinikolas G; Cameron-Smith D; Wittert GA
Mol Cell Endocrinol; 2007 Mar; 267(1-2):63-9. PubMed ID: 17270342
[TBL] [Abstract][Full Text] [Related]
25. Anandamide decreases glomerular filtration rate through predominant vasodilation of efferent arterioles in rat kidneys.
Koura Y; Ichihara A; Tada Y; Kaneshiro Y; Okada H; Temm CJ; Hayashi M; Saruta T
J Am Soc Nephrol; 2004 Jun; 15(6):1488-94. PubMed ID: 15153559
[TBL] [Abstract][Full Text] [Related]
26. The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55.
Sharir H; Console-Bram L; Mundy C; Popoff SN; Kapur A; Abood ME
J Neuroimmune Pharmacol; 2012 Dec; 7(4):856-65. PubMed ID: 22454039
[TBL] [Abstract][Full Text] [Related]
27. The endocannabinoid system: a new target for the regulation of energy balance and metabolism.
Després JP
Crit Pathw Cardiol; 2007 Jun; 6(2):46-50. PubMed ID: 17667864
[TBL] [Abstract][Full Text] [Related]
28. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
[TBL] [Abstract][Full Text] [Related]
29. Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats.
Chen L; Zhang J; Li F; Qiu Y; Wang L; Li YH; Shi J; Pan HL; Li M
J Pain; 2009 Jul; 10(7):732-9. PubMed ID: 19409856
[TBL] [Abstract][Full Text] [Related]
30. Role for cannabinoid receptors in human proximal tubular hypertrophy.
Jenkin KA; McAinch AJ; Grinfeld E; Hryciw DH
Cell Physiol Biochem; 2010; 26(6):879-86. PubMed ID: 21220919
[TBL] [Abstract][Full Text] [Related]
31. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
32. Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms.
De Oliveira Alvares L; Genro BP; Diehl F; Quillfeldt JA
Neurobiol Learn Mem; 2008 Jul; 90(1):1-9. PubMed ID: 18342551
[TBL] [Abstract][Full Text] [Related]
33. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts.
Wagner JA; Abesser M; Harvey-White J; Ertl G
J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503
[TBL] [Abstract][Full Text] [Related]
34. The endocannabinoid anandamide regulates the peristaltic reflex by reducing neuro-neuronal and neuro-muscular neurotransmission in ascending myenteric reflex pathways in rats.
Sibaev A; Yuece B; Allescher HD; Saur D; Storr M; Kurjak M
Pharmacol Rep; 2014 Apr; 66(2):256-63. PubMed ID: 24911079
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro.
Iuvone T; Esposito G; De Filippis D; Bisogno T; Petrosino S; Scuderi C; Di Marzo V; Steardo L;
J Mol Med (Berl); 2007 Dec; 85(12):1379-92. PubMed ID: 17639288
[TBL] [Abstract][Full Text] [Related]
36. Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.
Gkoumassi E; Dekkers BG; Dröge MJ; Elzinga CR; Schmidt M; Meurs H; Zaagsma J; Nelemans SA
Br J Pharmacol; 2007 Aug; 151(7):1041-8. PubMed ID: 17558435
[TBL] [Abstract][Full Text] [Related]
37. Anandamide inhibits endothelin-1 production by human cultured endothelial cells: a new vascular action of this endocannabinoid.
Ronco AM; Llanos M; Tamayo D; Hirsch S
Pharmacology; 2007; 79(1):12-6. PubMed ID: 17114903
[TBL] [Abstract][Full Text] [Related]
38. Cannabinoid type 1 receptor modulates intestinal propulsion by an attenuation of intestinal motor responses within the myenteric part of the peristaltic reflex.
Yuece B; Sibaev A; Broedl UC; Marsicano G; Göke B; Lutz B; Allescher HD; Storr M
Neurogastroenterol Motil; 2007 Sep; 19(9):744-53. PubMed ID: 17727394
[TBL] [Abstract][Full Text] [Related]
39. IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei.
Currie S; Rainbow RD; Ewart MA; Kitson S; Pliego EH; Kane KA; McCarron JG
J Mol Cell Cardiol; 2008 Dec; 45(6):804-11. PubMed ID: 18692061
[TBL] [Abstract][Full Text] [Related]
40. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.
Bermúdez-Siva FJ; Serrano A; Diaz-Molina FJ; Sánchez Vera I; Juan-Pico P; Nadal A; Fuentes E; Rodríguez de Fonseca F
Eur J Pharmacol; 2006 Feb; 531(1-3):282-4. PubMed ID: 16423347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
